HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephanie Dodd Selected Research

asciminib

1/2022Pharmacokinetics of Asciminib When Taken With Imatinib or With Food.
1/2017The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephanie Dodd Research Topics

Disease

1Leukemia
01/2022
1Glioblastoma (Glioblastoma Multiforme)
07/2018
1Neoplasms (Cancer)
07/2018
1Glioma (Gliomas)
07/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018
1Philadelphia Chromosome
01/2017

Drug/Important Bio-Agent (IBA)

2asciminibIBA
01/2022 - 01/2017
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2018
1Biomarkers (Surrogate Marker)IBA
07/2018
1Oncogene Proteins (Oncogene Protein)IBA
01/2018